News | November 06, 2025
Ginkgo Bioworks and Bayer renew partnership to power the next wave of Ag Biologicals
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
RedHill has obtained a court-approved asset attachment in South Korea to prevent Kukbo from transferring or disposing of assets ahead of enforcement of the judgment
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
Kygevvi combines two pyrimidine nucleosides, doxecitine and doxribtimine, which act by integrating deoxycytidine and deoxythymidine into skeletal muscle mitochondrial DNA
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
Teva reported third quarter revenues of $4.5 billion, an increase of 3 per cent year-over-year.
Budesonide is indicated for mild to moderate active Crohn's disease involving the ileum and/or the ascending colon in adults and children 8 years of age and olde
This integrated center combines development, testing, evaluation, and industry-academia-research collaboration
_256_384.jpg)
The transaction is expected to be completed within one month from the signing of the definitive agreements.
Kulzer has consolidated the production of its core product, artificial teeth, at its facility in Germany
Subscribe To Our Newsletter & Stay Updated
